In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.

• Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.
• Amphetamine continues to dominate among people who use ATS in most countries in South-Eastern, and Western and Central Europe, although methamphetamine is more common in Cyprus, Czechia, Greece, Ireland, Slovakia and Türkiye.
• In most European countries, ATS is not a drug group for which many people enter drug treatment, except for Czechia, Estonia, Finland, Lativa, Poland, Slovakia and Türkiye, where the proportion of treated persons with ATS as their primary drug reaches 20 to 45 per cent.
• However, use of both amphetamine and methamphetamine has increased moderately over the past decade in these subregions, although there are differences among cities participating in wastewater monitoring.